<SEC-DOCUMENT>0001558370-17-009075-index.html : 20171128
<SEC-HEADER>0001558370-17-009075.hdr.sgml : 20171128
<ACCEPTANCE-DATETIME>20171128160513
ACCESSION NUMBER:		0001558370-17-009075
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171127
ITEM INFORMATION:		Termination of a Material Definitive Agreement
FILED AS OF DATE:		20171128
DATE AS OF CHANGE:		20171128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37581
		FILM NUMBER:		171225542

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-321-5554

	MAIL ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8-k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: f8-k.htm

</DOCUMENT>
</SEC-DOCUMENT>